1-6 of 6
heart disease risk factors
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical consequences of clonal hematopoiesis of indeterminate potential

David P. Steensma
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 264–269.
https://doi.org/10.1182/asheducation-2018.1.264
Published: 2018
Journal Articles

Cardiovascular care of patients with chronic myeloid leukemia (CML) on tyrosine kinase inhibitor (TKI) therapy

Mary C. Barber, Michael J. Mauro, Javid Moslehi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 110–114.
https://doi.org/10.1182/asheducation-2017.1.110
Published: 2017
Journal Articles

Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment

Flora E. van Leeuwen, Andrea K. Ng
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 323–330.
https://doi.org/10.1182/asheducation-2016.1.323
Published: 2016
Journal Articles

Management of Essential Thrombocythemia

Francisco Cervantes
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 215–221.
https://doi.org/10.1182/asheducation-2011.1.215
Published: 2011
Journal Articles

The Cardiovascular Pharmacology of COX-2 Inhibition

Susanne Fries, Tilo Grosser
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 445–451.
https://doi.org/10.1182/asheducation-2005.1.445
Published: 2005
Journal Articles

Chronic Myeloproliferative Disorders

Jerry L. Spivak, Giovanni Barosi, Gianni Tognoni, Tiziano Barbui, Guido Finazzi, Roberto Marchioli, Monia Marchetti
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 200–224.
https://doi.org/10.1182/asheducation-2003.1.200
Published: 2003